NCT07107750 2026-02-04
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
Washington University School of Medicine
Phase 1 Not yet recruiting
Washington University School of Medicine
The Second Affiliated Hospital of Shandong First Medical University
Shandong Cancer Hospital and Institute
Tongji Hospital
Shanghai Zhongshan Hospital